全部 标题 作者
关键词 摘要

PLOS ONE  2011 

Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances

DOI: 10.1371/journal.pone.0024585

Full-Text   Cite this paper   Add to My Lib

Abstract:

Gastrointestinal disturbances are commonly reported in children with autism, complicate clinical management, and may contribute to behavioral impairment. Reports of deficiencies in disaccharidase enzymatic activity and of beneficial responses to probiotic and dietary therapies led us to survey gene expression and the mucoepithelial microbiota in intestinal biopsies from children with autism and gastrointestinal disease and children with gastrointestinal disease alone. Ileal transcripts encoding disaccharidases and hexose transporters were deficient in children with autism, indicating impairment of the primary pathway for carbohydrate digestion and transport in enterocytes. Deficient expression of these enzymes and transporters was associated with expression of the intestinal transcription factor, CDX2. Metagenomic analysis of intestinal bacteria revealed compositional dysbiosis manifest as decreases in Bacteroidetes, increases in the ratio of Firmicutes to Bacteroidetes, and increases in Betaproteobacteria. Expression levels of disaccharidases and transporters were associated with the abundance of affected bacterial phylotypes. These results indicate a relationship between human intestinal gene expression and bacterial community structure and may provide insights into the pathophysiology of gastrointestinal disturbances in children with autism.

References

[1]  Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, et al. (2010) Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125: Suppl 1S1–18.
[2]  White JF (2003) Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 228: 639–649.
[3]  Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, et al. (2000) Enterocolitis in children with developmental disorders. Am J Gastroenterol 95: 2285–2295.
[4]  Wakefield AJ, Ashwood P, Limb K, Anthony A (2005) The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 17: 827–836.
[5]  Furlano RI, Anthony A, Day R, Brown A, McGarvey L, et al. (2001) Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 138: 366–372.
[6]  Torrente F, Ashwood P, Day R, Machado N, Furlano RI, et al. (2002) Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7: 375–382, 334.
[7]  Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT (1999) Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 135: 559–563.
[8]  Ashwood P, Wills S, Van de Water J (2006) The immune response in autism: a new frontier for autism research. J Leukoc Biol 80: 1–15.
[9]  Ashwood P, Anthony A, Torrente F, Wakefield AJ (2004) Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24: 664–673.
[10]  Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, et al. (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 23: 504–517.
[11]  Enstrom AM, Onore CE, Van de Water JA, Ashwood P (2010) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24: 64–71.
[12]  Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B (2005) Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51: 77–85.
[13]  D'Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, et al. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr 85: 1076–1079.
[14]  Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, et al. (2002) Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35: S6–S16.
[15]  Song Y, Liu C, Finegold SM (2004) Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70: 6459–6465.
[16]  Parracho HM, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54: 987–991.
[17]  Knivsberg AM, Reichelt KL, Hoien T, Nodland M (2002) A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 5: 251–261.
[18]  Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, et al. (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15: 429–435.
[19]  Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA (2011) Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol 11: 22.
[20]  Sonnenburg ED, Sonnenburg JL, Manchester JK, Hansen EE, Chiang HC, et al. (2006) A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism. Proc Natl Acad Sci U S A 103: 8834–8839.
[21]  Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA (2008) Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6: 121–131.
[22]  Wong JM, Jenkins DJ (2007) Carbohydrate digestibility and metabolic effects. J Nutr 137: 2539S–2546S.
[23]  Jacobs DM, Gaudier E, van Duynhoven J, Vaughan EE (2009) Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Curr Drug Metab 10: 41–54.
[24]  O'Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7: 688–693.
[25]  Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4: 478–485.
[26]  Heijtz RD, Wang S, Anuar F, Qian Y, Bjorkholm B, et al. (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108: 3047–3052.
[27]  Richler J, Luyster R, Risi S, Hsu WL, Dawson G, et al. (2006) Is there a ‘regressive phenotype’ of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. J Autism Dev Disord 36: 299–316.
[28]  Kellett GL, Brot-Laroche E, Mace OJ, Leturque A (2008) Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 28: 35–54.
[29]  Khurana S, George SP (2008) Regulation of cell structure and function by actin-binding proteins: villin's perspective. FEBS Lett 582: 2128–2139.
[30]  Arijs I, De Hertogh G, Lemaire K, Quintens R, Van Lommel L, et al. (2009) Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment. PLoS One 4: e7984.
[31]  Suh E, Traber PG (1996) An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 16: 619–625.
[32]  Troelsen JT, Mitchelmore C, Spodsberg N, Jensen AM, Noren O, et al. (1997) Regulation of lactase-phlorizin hydrolase gene expression by the caudal-related homoeodomain protein Cdx-2. Biochem J 322(Pt 3): 833–838.
[33]  Uesaka T, Kageyama N, Watanabe H (2004) Identifying target genes regulated downstream of Cdx2 by microarray analysis. J Mol Biol 337: 647–660.
[34]  Balakrishnan A, Stearns AT, Rhoads DB, Ashley SW, Tavakkolizadeh A (2008) Defining the transcriptional regulation of the intestinal sodium-glucose cotransporter using RNA-interference mediated gene silencing. Surgery 144: 168–173.
[35]  Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, et al. (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68: 3401–3407.
[36]  Rauch M, Lynch SV (2010) Probiotic manipulation of the gastrointestinal microbiota. Gut Microbes 1: 335–338.
[37]  Vesper BJ, Jawdi A, Altman KW, Haines GK 3rd, Tao L, et al. (2009) The effect of proton pump inhibitors on the human microbiota. Curr Drug Metab 10: 84–89.
[38]  Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280.
[39]  Gurney JG, McPheeters ML, Davis MM (2006) Parental report of health conditions and health care use among children with and without autism: National Survey of Children's Health. Arch Pediatr Adolesc Med 160: 825–830.
[40]  Scheepers A, Joost HG, Schurmann A (2004) The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J Parenter Enteral Nutr 28: 364–371.
[41]  Swallow DM (2003) Genetic influences on carbohydrate digestion. Nutr Res Rev 16: 37–43.
[42]  Hodin RA, Chamberlain SM, Meng S (1995) Pattern of rat intestinal brush-border enzyme gene expression changes with epithelial growth state. Am J Physiol 269: C385–391.
[43]  Kishi K, Tanaka T, Igawa M, Takase S, Goda T (1999) Sucrase-isomaltase and hexose transporter gene expressions are coordinately enhanced by dietary fructose in rat jejunum. J Nutr 129: 953–956.
[44]  Tanaka T, Suzuki A, Kuranuki S, Mochizuki K, Suruga K, et al. (2008) Higher expression of jejunal LPH gene in rats fed the high-carbohydrate/low-fat diet compared with those fed the low-carbohydrate/high-fat diet is associated with in vitro binding of Cdx-2 in nuclear proteins to its promoter regions. Life Sci 83: 122–127.
[45]  Mochizuki K, Honma K, Shimada M, Goda T (2010) The regulation of jejunal induction of the maltase-glucoamylase gene by a high-starch/low-fat diet in mice. Mol Nutr Food Res 54: 1445–1451.
[46]  Bandini LG, Anderson SE, Curtin C, Cermak S, Evans EW, et al. (2010) Food selectivity in children with autism spectrum disorders and typically developing children. J Pediatr 157: 259–264.
[47]  Levy SE, Souders MC, Ittenbach RF, Giarelli E, Mulberg AE, et al. (2007) Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol Psychiatry 61: 492–497.
[48]  Herndon AC, DiGuiseppi C, Johnson SL, Leiferman J, Reynolds A (2009) Does nutritional intake differ between children with autism spectrum disorders and children with typical development? J Autism Dev Disord 39: 212–222.
[49]  Emond A, Emmett P, Steer C, Golding J (2010) Feeding symptoms, dietary patterns, and growth in young children with autism spectrum disorders. Pediatrics 126: e337–342.
[50]  Shearer TR, Larson K, Neuschwander J, Gedney B (1982) Minerals in the hair and nutrient intake of autistic children. J Autism Dev Disord 12: 25–34.
[51]  Raiten DJ, Massaro T (1986) Perspectives on the nutritional ecology of autistic children. J Autism Dev Disord 16: 133–143.
[52]  Schreck KA, Williams K, Smith AF (2004) A comparison of eating behaviors between children with and without autism. J Autism Dev Disord 34: 433–438.
[53]  Matosin-Matekalo M, Mesonero JE, Delezay O, Poiree JC, Ilundain AA, et al. (1998) Thyroid hormone regulation of the Na+/glucose cotransporter SGLT1 in Caco-2 cells. Biochem J 334(Pt 3): 633–640.
[54]  Emvo EN, Raul F, Koch B, Neuville P, Foltzer-Jourdainne C (1996) Sucrase-isomaltase gene expression in suckling rat intestine: hormonal, dietary, and growth factor control. J Pediatr Gastroenterol Nutr 23: 262–269.
[55]  Ziambaras T, Rubin DC, Perlmutter DH (1996) Regulation of sucrase-isomaltase gene expression in human intestinal epithelial cells by inflammatory cytokines. J Biol Chem 271: 1237–1242.
[56]  Suzuki K, Hashimoto K, Iwata Y, Nakamura K, Tsujii M, et al. (2007) Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism. Biol Psychiatry 62: 267–269.
[57]  Iseri E, Guney E, Ceylan MF, Yucel A, Aral A, et al. (2010) Increased Serum Levels of Epidermal Growth Factor in Children with Autism. J Autism Dev Disord.
[58]  Curin JM, Terzic J, Petkovic ZB, Zekan L, Terzic IM, et al. (2003) Lower cortisol and higher ACTH levels in individuals with autism. J Autism Dev Disord 33: 443–448.
[59]  Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, et al. (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881–884.
[60]  Barros R, Marcos N, Reis CA, De Luca A, David L, et al. (2009) CDX2 expression is induced by Helicobacter pylori in AGS cells. Scand J Gastroenterol 44: 124–125.
[61]  Ikeda H, Sasaki M, Ishikawa A, Sato Y, Harada K, et al. (2007) Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab Invest 87: 559–571.
[62]  Nguyen HT, Dalmasso G, Powell KR, Yan Y, Bhatt S, et al. (2009) Pathogenic bacteria induce colonic PepT1 expression: an implication in host defense response. Gastroenterology 137: 1435–1447 e1431–1432.
[63]  Dalmasso G, Nguyen HT, Yan Y, Charrier-Hisamuddin L, Sitaraman SV, et al. (2008) Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity. PLoS One 3: e2476.
[64]  Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS (1989) Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 84: 1056–1062.
[65]  Robayo-Torres CC, Quezada-Calvillo R, Nichols BL (2006) Disaccharide digestion: clinical and molecular aspects. Clin Gastroenterol Hepatol 4: 276–287.
[66]  Flint HJ, Duncan SH, Scott KP, Louis P (2007) Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 9: 1101–1111.
[67]  O'Keefe SJ (2008) Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 24: 51–58.
[68]  Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, et al. (2010) Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141: 1241–1252.
[69]  Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, et al. (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16: 444–453.
[70]  Gillevet P, Sikaroodi M, Keshavarzian A, Mutlu EA (2010) Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers 7: 1065–1075.
[71]  Marteau P, Pochart P, Dore J, Bera-Maillet C, Bernalier A, et al. (2001) Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl Environ Microbiol 67: 4939–4942.
[72]  Momozawa Y, Deffontaine V, Louis E, Medrano JF (2011) Characterization of Bacteria in Biopsies of Colon and Stools by High Throughput Sequencing of the V2 Region of Bacterial 16S rRNA Gene in Human. PLoS One 6: e16952.
[73]  Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, et al. (2005) Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol 71: 4679–4689.
[74]  Louis P, Young P, Holtrop G, Flint HJ (2010) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12: 304–314.
[75]  Duncan SH, Louis P, Thomson JM, Flint HJ (2009) The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 11: 2112–2122.
[76]  Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022–1023.
[77]  Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102: 11070–11075.
[78]  Collins SM, Bercik P (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136: 2003–2014.
[79]  Gupta G, Gelfand JM, Lewis JD (2005) Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129: 819–826.
[80]  Fullwood A, Drossman DA (1995) The relationship of psychiatric illness with gastrointestinal disease. Annu Rev Med 46: 483–496.
[81]  Lossos A, River Y, Eliakim A, Steiner I (1995) Neurologic aspects of inflammatory bowel disease. Neurology 45: 416–421.
[82]  Bushara KO (2005) Neurologic presentation of celiac disease. Gastroenterology 128: S92–97.
[83]  Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–1031.
[84]  Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, et al. (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159: 1739–1745.
[85]  Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, et al. (2004) Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558: 263–275.
[86]  Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, et al. (2008) Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One 3: e3140.
[87]  Williams BL, Yaddanapudi K, Hornig M, Lipkin WI (2007) Spatiotemporal analysis of purkinje cell degeneration relative to parasagittal expression domains in a model of neonatal viral infection. J Virol 81: 2675–2687.
[88]  Williams BL, Yaddanapudi K, Kirk CM, Soman A, Hornig M, et al. (2006) Metallothioneins and zinc dysregulation contribute to neurodevelopmental damage in a model of perinatal viral infection. Brain Pathol 16: 1–14.
[89]  Williams BL, Lipkin WI (2006) Endoplasmic reticulum stress and neurodegeneration in rats neonatally infected with borna disease virus. J Virol 80: 8613–8626.
[90]  Buning C, Ockenga J, Kruger S, Jurga J, Baier P, et al. (2003) The C/C(?13910) and G/G(?22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease. Scand J Gastroenterol 38: 538–542.
[91]  Hamady M, Walker JJ, Harris JK, Gold NJ, Knight R (2008) Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 5: 235–237.
[92]  Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780–13785.
[93]  Guo X, Xia X, Tang R, Zhou J, Zhao H, et al. (2008) Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 47: 367–373.
[94]  Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM (2007) Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol 8: R143.
[95]  Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, et al. (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75: 7537–7541.

Full-Text

comments powered by Disqus